[HTML][HTML] Functionalized liposomes for targeted breast cancer drug delivery

J Nel, K Elkhoury, É Velot, A Bianchi, S Acherar… - Bioactive materials, 2023 - Elsevier
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association

LS Mehta, KE Watson, A Barac, TM Beckie, V Bittner… - Circulation, 2018 - Am Heart Assoc
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …

[HTML][HTML] Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

Collaborative Group on Hormonal Factors in Breast … - The Lancet, 2019 - Elsevier
Background Published findings on breast cancer risk associated with different types of
menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term …

[图书][B] Патология матки. Руководство для врачей

Н Кондриков, И Баринова - 2020 - books.google.com
В практическом пособии рассматриваются основные принципы морфологического
исследования при заболеваниях матки, гистофизиологические изменения шейки матки …

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

C Fribbens, B O'Leary, L Kilburn, S Hrebien… - Journal of clinical …, 2016 - ascopubs.org
Purpose ESR1 mutations are selected by prior aromatase inhibitor (AI) therapy in advanced
breast cancer. We assessed the impact of ESR1 mutations on sensitivity to standard …

[HTML][HTML] Everolimus in postmenopausal hormone-receptor–positive advanced breast cancer

J Baselga, M Campone, M Piccart… - … England Journal of …, 2012 - Mass Medical Soc
Background Resistance to endocrine therapy in breast cancer is associated with activation
of the mammalian target of rapamycin (mTOR) intracellular signaling pathway. In early …

Effects of age on the detection and management of breast cancer

A McGuire, JAL Brown, C Malone, R McLaughlin… - Cancers, 2015 - mdpi.com
Currently, breast cancer affects approximately 12% of women worldwide. While the
incidence of breast cancer rises with age, a younger age at diagnosis is linked to increased …

The role of estrogens in control of energy balance and glucose homeostasis

F Mauvais-Jarvis, DJ Clegg, AL Hevener - Endocrine reviews, 2013 - academic.oup.com
Estrogens play a fundamental role in the physiology of the reproductive, cardiovascular,
skeletal, and central nervous systems. In this report, we review the literature in both rodents …

Uterine fibroids: current perspectives

AT Khan, M Shehmar, JK Gupta - International journal of women's …, 2014 - Taylor & Francis
Uterine fibroids are a major cause of morbidity in women of a reproductive age (and
sometimes even after menopause). There are several factors that are attributed to underlie …

An overview on estrogen receptors signaling and its ligands in breast cancer

MZI Khan, M Uzair, A Nazli, JZ Chen - European Journal of Medicinal …, 2022 - Elsevier
Estrogen governs the regulations of various pathological and physiological actions
throughout the body in both males and females. Generally, 17β-estradiol an endogenous …